Clinigen (CLIN)

Company name:Clinigen Group Plc
EPIC:CLINTrading Currency:GBX
Market Sector:AS50ISIN:GB00B89J2419
Market Segment:AMSMShare Type:DE
WWW Address:http://www.clinigen.co.uk/investorsDescription:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 849.50 images.advfn.com/imagesnew/2/gb/down -16.0 [-1.85] 849.00 850.50 875.00 875.00 847.00 154,323
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 1,125.41 132.48 0.51 22.90 5.60 37.10 0.66 1,069.00 - 716.00

Clinigen Key Figures

(at previous day's close)
Market Cap.1,125.41m
Shares In Issue132.48m
Prev. Close865.50
PE Ratio37.10 
Dividend Yield0.66%
EPS - basic22.90p
Dividend PS5.60p
Dividend Cover4.09 
Cash Flow PS35.93p
Return On Equity (ROE)7.84%
Operating Margin9.42%
PEG Factor0.06 
EPS Growth Rate593.94%
Dividends PS Growth Rate12.00%
Net Debt281.30m
Gross Gearing47.61%
Quick Assets134.80m
Net Working Capital42.30m
Intangibles / Fixed Assets97.38%
Turnover PS287.74p
Pre-Tax Profit PS27.10p
Retained Profit PS15.93p
Cash PS27.40p
Net Cash PS-58.50p
Net Tangible Asset Value PS *-111.79p
Net Asset Value PS263.82p
Spread1.50 (0.18%) 

Clinigen Balance Sheet

CLIN:Liabilities+EQCLIN:Assets

Share Price Performance

Sample Period HighLow
1 week895.50825.00
4 weeks895.50801.00
12 weeks959.00777.50
1 year1,069.00716.00

Share Price Chart (5 years)

Clinigen Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week895.50-46.00-5.14825.000.19861.13
4 weeks862.50-13.00-1.51801.000.17861.62
12 weeks874.00-24.50-2.80777.500.28852.94
26 weeks1,013.00-163.50-16.14777.500.26900.61
1 year811.0038.504.75716.000.30896.02
3 years700.00149.5021.36700.000.35931.33
5 years539.50310.0057.46483.750.37799.47

Clinigen Key Management Ratios

Clinigen Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio117.31 
PE Ratio37.10 
Tobin's Q Ratio 2.00 
Tobin's Q Ratio (excl. intangibles)7.59 
Dividend Yield0.66%
Market-to-Book Ratio3.22 
Price-to-Pre-Tax Profit PS31.35 
Price-to-Retained Profit PS53.34 
Price-to-Cash Flow PS23.64 
Price-to-Sales PS2.95 
Price-to-Net Tangible Asset Value PS-7.60 
Price-to-Cash PS31.00 
Net Working Capital PS31.93 
Price Pct to Working Capital PS26.61%
Earnings Yield2.70%
Average PE95.01 
Years in average5 
PE to PE average39.04%

Clinigen Financial Ratios

(Leverage Ratios)
Debt Ratio36.83%
Debt-to-Equity Ratio0.58 
Debt-to-Equity Ratio (excl. Intgbl)-1.38 
Debt-to-Equity Market Value0.18 
Net Gearing42.17%
Net Gearing (excl. Intangibles)165.96%
Gross Gearing47.61%
Gross Gearing (excl. Intangibles)187.37%
Gearing Under 1 Year17.06%
Gearing Under 1 Year (excl. Intgbl)67.14%
Assets/Equity1.91 
Cash/Equity10.39 
(Liquidity Ratios)
Net Working Capital to Total Assets6.34%
Current Ratio1.37 
Quick Ratio (Acid Test)1.18 
Liquidity Ratio0.32 
Cash & Equiv/Current Assets23.25%
(Solvency Ratios)
Enterprise Value1,292.91m
CFO/Sales0.12 
CFO/Attributable Profit1.74 
CFO/Assets0.07 
CFO/Debt0.15 
Total Debt/Equity Market Value0.28 
Total Debt/Sales0.83 
Total Debt/Pre-Tax Profit8.85 
Total Debt317.60m
Total Debt/Net Current Assets7.51%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth24.38%
5 yr Compound Earnings Growth3.16%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
0.50660.4083

Clinigen Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)6.49%
Return On Assets (ROA)4.86%
Net Profit Margin7.19%
Assets Turnover0.68 
Return On Equity (ROE)7.84%
Return On Investment (ROI)6.52%
Dividend Payout Ratio24.45%
Plowback Ratio75.55%
Growth from Plowback Ratio6.92%
Net Income Of Revenues5.54%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.27 
Fixed Assets Turnover0.89 
Current Assets Turnover2.82 
Net Working Capital Turnover 
Inventory Turnover20.06 
(Other Operating Ratios)
Total Assets-to-Sales1.48 
Debtors-to-Sales22.04%
Debt Collection Period80.43Days

Clinigen Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
27 Feb 2019InterimGBX1.9501/07/201831/12/201821/03/201922/03/201912/04/2019-
27 Sep 2018FinalGBX3.8430/06/201730/06/201808/11/201809/11/201830/11/20185.60
27 Feb 2018InterimGBX1.7601/07/201731/12/201722/03/201823/03/201812/04/2018-
28 Sep 2017FinalGBX3.4030/06/201630/06/201709/11/201710/11/201701/12/20175.00
15 Mar 2017InterimGBX1.6001/07/201631/12/201623/03/201724/03/201713/04/2017-
28 Sep 2016FinalGBX2.7030/06/201530/06/201603/11/201604/11/201625/11/20164.00
02 Mar 2016InterimGBX1.3001/07/201531/12/201517/03/201618/03/201608/04/2016-
22 Sep 2015FinalGBX2.3030/06/201430/06/201515/10/201516/10/201506/11/20153.40
03 Mar 2015InterimGBX1.1001/07/201431/12/201412/03/201513/03/201502/04/2015-
24 Sep 2014FinalGBX2.1030/06/201330/06/201415/10/201417/10/201407/11/20143.10
26 Feb 2014InterimGBX1.0001/07/201331/12/201305/03/201407/03/201428/03/2014-
25 Sep 2013FinalGBX2.0030/06/201230/06/201309/10/201311/10/201301/11/20132.60
27 Feb 2013InterimGBX0.6001/07/201231/12/201206/03/201308/03/201328/03/2013-

Clinigen Fundamentals

 30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
turnover184.36100.00%339.90100.00%302.30100.00%381.20100.00%m
pre tax profit8.364.53%15.904.68%14.104.66%35.909.42%m
attributable profit5.262.85%13.503.97%3.801.26%27.407.19%m
retained profit2.621.42%9.402.77%-1.10-0.36%21.105.54%m
eps - basic (p)6.00 11.90 3.30 22.90 
eps - diluted (p)5.90 11.80 3.20 22.50 
dividends per share3.40 4.00 5.00 5.60 

Clinigen Balance Sheet

 30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
CLIN:Liabilities+EQCLIN:AssetsCLIN:Liabilities+EQCLIN:AssetsCLIN:Liabilities+EQCLIN:AssetsCLIN:Liabilities+EQCLIN:Assets
 30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
ASSETS
fixed assets fixed assets1.600.38%2.700.59%3.300.72%6.801.02%m
intangibles intangibles308.2273.44%333.7072.56%332.5072.36%497.6074.59%m
fixed investments fixed investments--%7.401.61%9.702.11%6.600.99%m
current assets - other current assets - other--%--%--%--%m
stocks stocks11.132.65%16.003.48%16.703.63%21.303.19%m
debtors debtors70.9716.91%72.3015.72%69.5015.13%98.5014.77%m
cash & securities cash & securities27.756.61%27.806.04%27.806.05%36.305.44%m
TOTAL419.67100%459.90100%459.50100%667.10100%m
LIABILITIES
creditors - short creditors - short161.5238.49%164.3035.73%171.7037.37%113.8017.06%m
creditors - long creditors - long53.5212.75%59.1012.85%38.708.42%203.8030.55%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL215.0451.24%223.4048.58%210.4045.79%317.6047.61%m
EQUITY
ord cap, reserves ord cap, reserves204.6248.76%236.5051.42%249.1054.21%349.5052.39%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL204.6248.76%236.5051.42%249.1054.21%349.5052.39%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Clinigen Cash Flow Statement

30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
Operating CF13.1342.1046.1047.60m
Pre-Financing CF-175.1711.7037.30-75.60m
Retained CF6.08-0.60-0.508.80m

Clinigen Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
CLIN
Clinigen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191210 03:18:43